Meldungen zum Thema Medizin

Abonnieren Sie alle Meldungen zum Thema Medizin

12.11.2018 – 12:01

Nyxoah S.A

Nyxoah Raises EUR15 Million in New Financing, Completes BLAST OSA Clinical Study

Mont-Saint-Guibert, Belgium (ots/PRNewswire) - Nyxoah S.A., a medical device company focused on the development and commercialization of a best-in-class hypoglossal nerve stimulation (HGNS) therapy for the treatment of Obstructive Sleep Apnea (OSA), announced today that it successfully raised an additional EUR15 million ($17.1 million USD) in their most ...

06.11.2018 – 09:02

Primary Care Diabetes Europe (PCDE)

Primary Care Diabetes Europe Issues Call to Action Against Clinical Inertia in the Treatment of Type-2 Diabetes

Ekeren, Belgium (ots/PRNewswire) - Research identifies lack of primary care physician adherence to treatment guidelines among the challenges to optimal care for patients with type-2 diabetes Primary Care Diabetes Europe (PCDE) today issued a call to action challenging primary care physicians and other healthcare ...

05.11.2018 – 12:10

Grünenthal Group

Grünenthal acquires global rights for Qutenza®

Aachen (ots) - Grünenthal, the science-focused pharmaceutical company based in Germany, announced today that it has acquired additional global commercial rights for the dermal pain patch Qutenza® (8% capsaicin) from Acorda Therapeutics, Inc (USA). Grünenthal is now the sole owner of Qutenza® worldwide, including the US, Latin America, Asia and Australia. Grünenthal had already acquired ...

05.11.2018 – 12:00

Sysmex Inostics GmbH

Sysmex Inostics OncoBEAM(TM) circulating tumor DNA technology demonstrates superior response prediction for advanced pancreatic cancer over standard-of-care protein biomarkers

Hamburg, Germany (ots) - Recent data published in Annals of Oncology (https://academic.oup.com/annonc/advance-article/doi/10.1093/annonc/mdy417/5139593) from a study conducted by Sysmex Inostics and University of Munich indicate that circulating tumor DNA (ctDNA) may offer clinicians higher-resolution information ...

01.11.2018 – 09:26

POLYTECH Health & Aesthetics GmbH

Breast Aesthetics Company POLYTECH Reveals New Brand Identity at ISAPS Congress, Focusing on Translating Quality Standards Into a Tangible Experience

Dieburg, Germany (ots/PRNewswire) - POLYTECH Health & Aesthetics GmbH, an international leader in Breast Aesthetics, announced today the launch of the new POLYTECH company branding and a new company website. POLYTECH Health & Aesthetics GmbH launches its new brand image at the ISAPS (International Society of ...

30.10.2018 – 08:43

Grünenthal Group

Grünenthal agrees US$ 922 m deal with AstraZeneca for Nexium and Vimovo

Aachen (ots) - - Biggest single investment in Grünenthal's history that will significantly strengthen the company's leading position in pain management - Gastroprotective therapies to address a high unmet medical need [1] in pain patients on non-steroidal anti-inflammatory drugs (NSAIDs) Grünenthal today announced that it has agreed to acquire ...

23.10.2018 – 15:24

COMPASS Pathways

COMPASS Pathways Receives FDA Breakthrough Therapy Designation for Psilocybin Therapy for Treatment-resistant Depression

London (ots/PRNewswire) - COMPASS Pathways, a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health, has received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for its psilocybin therapy for treatment-resistant depression. ...

23.10.2018 – 14:00

Debiopharm International SA

GenePOC® launches its GenePOC® CDiff test in Canada

Québec, Canada (ots) - GenePOC announces the Health Canada approval and launch of its molecular diagnostic test for the detection of Clostridium difficile in Canada GenePOC Inc., member of the Debiopharm Group, is proud to announce the approval by Health Canada and the launch of its GenePOC CDiff assay to be used with the revogene(TM) instrument. About the Clostridium difficile infection (CDI) In ...

22.10.2018 – 14:46

Merck KGaA

Merck Presents Updated Results for Bifunctional Immunotherapy M7824 at ESMO 2018 Congress

Darmstadt, Germany (ots/PRNewswire) - The information contained is not intended for distribution in the USA, Canada or the UK ESMO Abstract # M7824 (TGF ?-trap/anti-PD-L1): 10480, 1463P, 757P, 643P, 642P, 661P, 1931P - New data presented at the ESMO 2018 Congress include first disclosure of results for M7824 in advanced squamous cell carcinoma of the head ...

18.10.2018 – 12:00

Sysmex Inostics GmbH

Sysmex Inostics' OncoBEAM(TM) platform demonstrates superior detection of clinically-relevant mutations for therapy selection and molecular monitoring for lung and colon cancers

Hamburg, Germany (ots) - Data presented at the European Society of Medical Oncology (ESMO) 2018 meeting in Munich, Germany by three clinical oncology research groups demonstrate the importance of a highly sensitive test for detection of clinically-relevant mutations present in circulating tumor DNA (ctDNA) derived ...

18.10.2018 – 07:01

UCB Pharma

UCB Accelerates Anti-FcRn Rozanolixizumab in Myasthenia Gravis Into Confirmatory Development Phase

Brussels (ots/PRNewswire) - - Positive outcomes in proof-of-concept study with subcutaneous rozanolixizumab in patients with myasthenia gravis (MG): clinically meaningful improvement in multiple disease-related endpoints - Strong 68% mean reduction of Serum IgG and IgG Autoantibodies observed - Safety profile ...

17.10.2018 – 17:36

Hovione

Hovione Increases Production Capacity

Loures, Portugal (ots/PRNewswire) - 'One Site Shop' expands to respond to growing demands Hovione announces plan to increase production capacity in oral dosage forms in Portugal, to strengthen the integrated offering. New commercial scale equipment for blending, tableting and coating will complement existing development small scale equipment. This decision to expand follows growing customer demand ...

17.10.2018 – 13:31

Accuray

Accuray Showcases Radiation Therapy Innovations Designed to Improve What's Possible for Patients at ASTRO 2018

Sunnyvale, California (ots/PRNewswire) - Building on its heritage of patient-first innovation, at this year's ASTRO (American Society for Radiation Oncology) Annual Meeting, Accuray Incorporated (NASDAQ: ARAY) will showcase radiation therapy solutions designed to enable clinicians to deliver truly personalized ...

17.10.2018 – 13:20

Merck KGaA

Merck Inaugurates State-of-the-art Pharma Packaging Center in Darmstadt

Darmstadt, Germany (ots/PRNewswire) - - Expansion of the pharma manufacturing site at Merck's headquarters supports growth of current and future portfolio of pharma medicines - New building dedicated to the packaging and shipping of Merck's pharma medicines in more than 90 countries - EUR63 million investment in new packaging center is part of wider EUR1 ...

15.10.2018 – 13:06

Sysmex Inostics GmbH

Sysmex Inostics' OncoBEAM(TM) liquid biopsy technology demonstrates utility for clinical management of melanoma patients undergoing treatment with targeted therapy and immune checkpoint inhibitors

Hamburg, Germany (ots) - Sysmex Inostics, a pioneer in blood-based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, is pleased to announce publication of a study in the Journal of Molecular Oncology highlighting the important clinical value of blood-based ctDNA mutation testing to ...

12.10.2018 – 09:00

European Society for Medical Oncology (ESMO)

Breast cancer patients use Twitter as a non-medical forum to share their experiences

Lugano/Munich (ots) - Twitter is a place where many cancer patients share and discuss their experiences, a study at the ESMO 2018 Congress reveals, based on analysis of the contents of over 6,000 tweets and retweets about breast cancer. The study was part of a larger, multidisciplinary project to observe the presence of different diseases on social media. ...

11.10.2018 – 19:31

Merck KGaA

Global Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosis

Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S media - Merck-sponsored survey developed in collaboration with IACO and Eurocarers reveals lifelong effects of caring for a loved one with MS - #MSInsideOut documentary film, executively produced by Shift.ms, provides artistic take on the experiences of those impacted by MS Merck, a leading science ...

11.10.2018 – 12:57

Janssen Pharmaceutica

Janssen to highlight data from broad rheumatology portfolio at the 2018 Annual meeting of the American College of Rheumatology

Beerse, Belgium (ots/PRNewswire) - - One-year results from the Phase 2 study evaluating STELARA® (ustekinumab) in patients with active systemic lupus erythematosus featured in a plenary presentation - 13 presentations from approved and pipeline products provide real-world treatment and disease insights across ...

11.10.2018 – 12:00

Debiopharm International SA

Debiopharm International SA and the Paul Scherrer Institute announce a licensing agreement for the development of a novel targeted radiotherapeutic product in Oncology

Lausanne, Villigen, Switzerland (ots) - Debiopharm International SA (Debiopharm), a Swiss-based biopharmaceutical company and the Paul Scherrer Institute (PSI), the largest research institute for natural and engineering sciences in Switzerland, today announced a collaboration to pursue the development of a ...

11.10.2018 – 08:04

Gerresheimer AG

Gerresheimer Increases Revenues by 8.8% and Successfully Integrates Sensile Medical

Düsseldorf, Germany (ots/PRNewswire) - - Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m - Adjusted EBITDA at constant exchange rates-excluding Sensile Medical and negative effects relating to the exemption from electricity network charges-increased by EUR 1.3m in third quarter to ...

10.10.2018 – 07:10

PAUL HARTMANN AG

Britta Fuenfstueck appointed as new CEO of the HARTMANN GROUP

09.10.2018 – 08:01

Merck KGaA

Merck Data at ESMO 2018 Congress Highlight Multiple Therapeutics with Potential to Transform Cancer Care

Darmstadt, Germany (ots/PRNewswire) - Not intended for distribution in the USA, Canada or UK ESMO Abstract # Avelumab: LBA6_PR, 659P, 1290P, 1291P, 1282P, 877P; M7824 (TGF ?-trap/anti-PD-L1):1048O, 1463P, 1931P, 757P, 643P, 642P, 661P; tepotinib (MET kinase inhibitor): 1377O, 621PD, 698P; M6620: 1437P; M3814: 1845P; ...

02.10.2018 – 14:30

Sysmex Europe GmbH

In vitro diagnostics company Sysmex Europe announces executive leadership change

Norderstedt (ots) - Sysmex Europe GmbH, which oversees Sysmex's operations in EMEA (Europe, Middle East & Africa), has announced its Chairman and long-time President & CEO Dr Jürgen Schulze decided in early 2018 to retire effective 30 September 2018, however will continue to benefit and support Sysmex as a member and vice-chairman of the MedTech Europe ...

02.10.2018 – 12:00

Novo Nordisk A/S

People With Diabetes May Achieve Improved Glycaemic Control With Tresiba® Versus Glargine U100, Without an Increase in Hypoglycaemia

Berlin (ots/PRNewswire) - According to results of a post-hoc analysis people with both type 1 and type 2 diabetes in clinical practice may achieve improved glycaemic control (HbA1c) with Tresiba® (insulin degludec) versus insulin glargine U100, without an increase in hypoglycaemia (potentially dangerous low blood ...

02.10.2018 – 12:00

Novo Nordisk A/S

Ryzodeg® Offers a Simpler Solution With Once-Daily Dosing and Reduced Risk of Nocturnal Hypoglycaemia vs Insulin Glargine U100 Plus Insulin Aspart

Berlin (ots/PRNewswire) - When treated with once-daily Ryzodeg®, people with type 2 diabetes achieved similar blood sugar control with half the number of daily injections, significantly lower total daily insulin dose and significantly reduced risk of nocturnal hypoglycaemia in the Step by Step trial compared with ...

02.10.2018 – 12:00

Novo Nordisk A/S

Addressing Social and Cultural Drivers of Type 2 Diabetes is Key to Its Treatment and Prevention

Berlin (ots/PRNewswire) - New research shows healthcare services and public health strategies aimed at reducing the burden of type 2 diabetes may prove ineffective, unless they address social and cultural factors.[1] Researchers linked factors such as food traditions and traditional gender roles to increasing ...

01.10.2018 – 14:13

Zentiva

Generics Manufacturer Zentiva Starts Operations as Independent Company

Prague (ots/PRNewswire) - Today marks generics manufacturer Zentiva's first day as an independent organization, following completion of the company's previously announced divestment from Sanofi. Zentiva is headquartered in Prague, and the company - now backed by Advent International, one of the world's largest and most experienced global private equity ...

12345678910Nächste